Objective:

To discuss the analytical challenges in detecting nitrosamines in pharmaceuticals.

Key Findings:

• Mass spectrometry, particularly triple quadrupole instruments, is preferred for low-level quantitation of nitrosamines.
• Sample preparation and matrix effects are significant challenges in nitrosamine detection.
• Complex drug product matrices can hinder accurate recovery and detection of nitrosamines.
• Specificity is critical to avoid false positives due to background contamination.

Interpretation:

The detection of nitrosamines in pharmaceuticals is fraught with analytical challenges, primarily due to the need for high sensitivity and specificity in complex matrices.

Limitations:

• Availability of suitable reference materials can affect testing accuracy.
• Isotopically labeled internal standards are often not commercially available.

Conclusion:

Addressing these analytical challenges is essential for accurate detection and quantitation of nitrosamines in pharmaceutical products.